Pre-Health Discussion Forum: Patents & Pills, Prices & Profits

Discussion Questions: 1. Should the US introduce some form of price regulation for medicines? If so, how? 2. Intellectual property protections - mainly in the form of patents - are supposed to create incentives for innovation - including drug development. How well do you think this is working? Are there any possible alternatives to the current model? Readings: a. Scannell J. Four Reasons Drugs Are Expensive, Of Which Two Are False. Forbes.com October 13, 2015. https://www.forbes.com/sites/matthewherper/2015/10/13/four-reasons-drugs-are-expensive-of-which-two-are-false/#767128974c3b b. Light D, Lexchin J. Foreign free riders and the high price of US medicines BMJ 2005:331:958-60. http://www.bmj.com/content/331/7522/958.full.pdf c. Schrag D. The Price Tag on Progress — Chemotherapy for Colorectal Cancer. N Engl J Med 2004;351(4):317-319. http://www.nejm.org/doi/pdf/10.1056/NEJMp048143 d. Lakdawalla DN,Goldman DP,Michaud PC, Sood N. US Pharmaceutical Policy In A Global Marketplace. Health Affairs 2009;28(1):w138- w150. http://content.healthaffairs.org/content/28/1/w138.long

Categories
When	Nov 03, 2017 from 01:00 pm to 02:30 pm
Hosting organization	Pre-Health Advising Office
Speaker	Various Speakers
Speaker Information	Alex Orak
Where	Hunter East 710
Add event to calendar	vCal iCal